DeSalva AnnaMaria
Known title: DirectorCIK: 0001717049
Associated companies
Transaction History
| RXO | ▲ Buy | Option Exercise | 11,537 | $0 | 1/3/2024 | View on chart |
| RXO | ▲ Buy | Option Exercise | 6,890 | $0 | 1/3/2023 | View on chart |
| RXO | ▲ Buy | Option Exercise | 11,537 | $0 | 1/3/2024 | View on chart |
| RXO | ▲ Buy | Option Exercise | 6,890 | $0 | 1/3/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
RXO Stock Gains as C.H. Robinson Deal Lifts Analyst Targets
RXO Inc. is in focus after the C.H. Robinson deal anchored higher analyst price targets, with Truist Securities raising its target to $30. This development comes alongside broader transport sector discussions regarding diesel prices and small-cap valuation questions. The stock is currently trading near the top of its 52-week range, reflecting recent momentum driven by these fundamental updates.
RXO Stock Gains as C.H. Robinson Deal Lifts Analyst Targets. RXO Inc. is in focus after the C.H. Robinson deal anchored higher analyst price targets, with Truist Securities raising its target to $30. This development comes alongside broader transport sector discussions regarding diesel prices and small-cap valuation questions. The stock is currently trading near the top of its 52-week range, reflecting recent momentum driven by these fundamental updates.